双重抗血小板治疗持续时间 - The Left Main and Coronary Artery Bifurcation Lesion Summit (CBS)

文章摘要

Acute Coronary Syndrome, Antiplatelet Therapy, and Bleeding: A Clinical Perspective
Rivaroxaban Plus Aspirin in Patients With Vascular Disease and Renal Dysfunction: From the COMPASS Trial
Evolution of antithrombotic therapy in patients undergoing percutaneous coronary intervention: a 40-year journey
Dual Antiplatelet Therapy after PCI in Patients at High Bleeding Risk
Elaborately Engineering a Self-Indicating Dual-Drug Nanoassembly for Site-Specific Photothermal-Potentiated Thrombus Penetration and Thrombolysis
Gut microbiota induces high platelet response in patients with ST segment elevation myocardial infarction after ticagrelor treatment

|<<... 3 4 5 6 7 8 9 10 >>|

Review Article

2020 Jul 1;9(7):E2064.

JOURNAL：J Clin Med .

Article Link

Acute Coronary Syndrome, Antiplatelet Therapy, and Bleeding: A Clinical Perspective

G Tersalvi, L Biasco, GM Cioffi et al.

4979

Keywords: P2Y12 inhibition; acute coronary syndrome; bleeding; clopidogrel; dual antiplatelet therapy; high bleeding risk; prasugrel; tailored therapy; ticagrelor

Full Text PDF